Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction

Chinese Medical Journal

Volumn 122, Issue 2, 2009, Pages 183-187

  Zhuang, Yu ^a   Chen, Xin ^a   Xu, Ming ^a   Zhang, Lei Yang ^a   Xiang, Fei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemokine CXCL12; Homing behavior; Mesenchymal stem cells; Myocardial infarction

Indexed keywords

CYTOKINE ANTIBODY; SODIUM CHLORIDE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CELL COUNT; CELL CULTURE; CELL HOMING; CELL LABELING; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULARIZATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; STEM CELL TRANSPLANTATION;

EID: 60649116111     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.02.014     Document Type: Article

References (20)

1. Chen X, Xu M, Shi HW, Mu XW, Chen ZQ, Qiu ZB. Comparative study of on-pump and off-pump coronary bypass surgery in patients with triple-vessel coronary artery disease. Chin Med J 2004; 117: 342-346.
2. Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005; 100: 217-223.
3. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
4. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110: 3300-3305.
5. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
6. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100 (19 suppl): II247- II256.
7. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991; 260: H1406-H1414.
8. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994; 89: 345-354.
9. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004; 104: 2643-2645.
10. Bhakta S, Hong P, Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovas Revas Med 2006; 7: 19-24.
11. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006; 24: 1254-1264.
12. Shi M, Li J, Liao L, Chen B, Li B, Chen L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92: 897-904.
13. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27: 1114-1122.
14. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003; 107: 2134-2139.
15. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infracted myocardium. Nature 2001; 410: 701-705.
16. Qi CM, Ma GS, Liu NF, Shen CX, Chen Z, Liu XJ, et al. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model. Chin Med J 2008; 121: 544-550.
17. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008; 44: 486-495.
18. Rehman J, Li J, Orschell C, March K. Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
19. Zhao W, Lu L, Chen SS, Sun Y. Temporal and spatial characteristics of apoptosis in the infarcted rat heart. Biochem Biophys Res Commun 2004; 325: 605-611.
20. Krausgrill B, Schwinger RH, Müller-Ehmsen J. Mesenchymal stem cells for cardiac regeneration. Med Klin (Munich) 2006; 101 Suppl 1: 202-206.